Author

Eva Havrdová

Charles UniversityORCID 0000-0002-9543-4359Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Allan G. KermodeiD· 2 shared Bruce V. TayloriD· 2 shared Helmut ButzkueveniD· 2 shared Jeannette Lechner‐ScottiD· 2 shared Mark SleeiD· 2 shared Vilija JokubaitisiD· 2 shared Alessandra LugaresiiD· 1 shared Alexandre PratiD· 1 shared

Activity by Year

2019-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Allan G. KermodeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

C4 genetic structural variations affect multiple sclerosis risk and progression

Xin Lin, Dongdong Tang, Yuanhao Yang, Maria Pia Campagna, Melissa M. Gresle, Wei Zhen Yeh, Sandeep Sampangi, Pavlína Kleinová, Fuencisla Matesanz, Antonio Alcina, Sara Eichau, Marzena J. Fabis‐Pedrini, Mark Slee, Allan G. Kermode, Trevor John Kilpatrick, , Yuan Zhou

The paper investigates C4 genetic structural variations in multiple sclerosis, finding associations with disease risk and progression, and links them to immune cell expression and pathways.

medRxiv · Jul 28, 2025 · PreprintGenetic & Genomic Medicine

Immunotherapy prevents long-term disability in relapsing multiple sclerosis over 15 years

Tomáš Kalinčík, Sifat Sharmin, Charles Benjamin Malpas, Tim D. Spelman, Dana Horáková, Eva Havrdová, María Trojano, Guillermo Izquierdo, Alessandra Lugaresi, Alexandre Prat, Marc Girard, Pierre Duquette, Pierre Grammond, Vilija Jokubaitis, Anneke van der Walt, , on behalf of the MSBase Study group

This study shows that immunotherapy reduces disability and relapses in relapsing multiple sclerosis over 15 years.

bioRxiv · Aug 23, 2019 · PreprintNeuroscience